European community pharmacists are in the frontline in the fight against the novel coronavirus disease (COVID-19) and they are doing everything in their power to support their patients, including in areas currently in lockdown. This pages provides insights in the roles and commitments of community pharmacists in the fight against COVID-19 and gives an overview of useful international and national resources for community pharmacists.
By demonstrating solidarity in the ways that Member States cope with infectious disease outbreaks, Europe will provide an enduring example and a precedent for addressing future pandemics. However, solidarity must extend to vulnerable regions outside the European Union – particularly, but not necessarily limited to, low and middle income countries, and especially the most vulnerable within them. Pathogens do not respect national borders. COVID-19...
What you need to know • Most patients with covid-19 can be managed remotely with advice on symptomatic management and self isolation • Although such consultations can be done by telephone in many cases, video provides additional visual cues and therapeutic presence • Breathlessness is a concerning symptom, though there is currently no validated tool for assessing it remotely • Safety-netting advice is crucial because some patients deteriorate...
Here is an online first Comment in the Lancet, published this morning, about the need to scale a national community health worker response to the COVID19 crisis in the UK.
The European Centre for Disease Control has published a 'support' document in order to help with public health preparedness planning and response activities when advising healthcare services on approaches on how to increase capacity for managing COVID-19 cases. This is done in the context of widespread sustained SARS-CoV-2 transmission. This document is aimed at public health authorities and healthcare administrators in the EU/EEA and the UK.
Table of contents What's newSupporting the development of medicines and vaccinesAdvice on clinical trialsMonitoring the impact on medicine supply chainsAdvice on using non-steroidal anti-inflammatory medicines such as ibuprofenWorking with EU and international partnersImpact on EMA activities and meetings
Go to COVID-19 Latest updates page
Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis
Community engagement is the first line of defence in the battle against infectious diseases. GPs are both gatekeepers and health promotors by empowering the community to build a firewall against the deadly virus. GPs are engaged in each of the three phases of response to the disease. For example, they help block the viral transmission in phase 1 by monitoring people at designated checkpoints, and they slow the increase of cases by treating patien...